ライフサイエンスコーパス: blood pressure reduction

1 s expected to reduce it in proportion to the blood pressure reduction.

2 ry prevention of HF is strongly dependent on blood pressure reduction.

3 Recent trials underscore the importance of blood pressure reduction.

4 t by virtue of their effects over and beyond blood pressure reduction.

5 sive treatment, despite little difference in blood pressure reduction.

6 death, predominantly stroke, independent of blood pressure reduction.

7 recognized benefits of glycemic control and blood pressure reduction.

8 ditions have focused on glycemic control and blood pressure reduction.

9 iated with improved prognosis independent of blood pressure reduction.

10 program, particularly for smoking, diet, and blood pressure reduction.

11 s on LV mass independent of the magnitude of blood pressure reduction.

12 ing of the mechanisms resulting in sustained blood pressure reduction.

13 ration of significant systolic and diastolic blood pressure reductions.

14 uctions proportional to the magnitude of the blood pressure reductions achieved.

15 s placebo-corrected 24-h systolic ambulatory blood pressure reduction after 4 weeks and analysis was

16 We report marked blood pressure reduction after RDN in a patient with res

17 en the A allele of beta2-AR G46A and greater blood pressure reduction and blunted aldosterone and PRA

18 f the SPS3 trial, we aimed to assess whether blood pressure reduction and dual antiplatelet treatment

19 ressure-lowering therapy is the magnitude of blood pressure reduction and perhaps the speed at which

20 or the amlodipine group, correlation between blood pressure reduction and progression was r = 0.19, P

21 ous and rare, produce clinically significant blood pressure reduction and protect from development of

22 Blood pressure reduction and renin-angiotensin-aldostero

23 Blood pressure reductions and numbers of events were sma

24 he ACE inhibitor dose, the ARB and its dose, blood pressure reduction, and patient populations-to pre

25 causes regression of ECG-LVH independent of blood pressure reduction, and these changes are associat

26 tus suggested that despite achieving similar blood pressure reductions, angiotensin-converting enzyme

27 ions in input parameters except for systolic blood pressure reduction, baseline systolic blood pressu

28 The difference in blood pressure reduction between the two groups was not

29 Blood pressure reduction by consumption of cocoa product

30 FE, and ALLHAT underscores the importance of blood pressure reduction for patients with coronary arte

31 nostic significance of dIVH in the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage T

32 f the pilot and main phases of the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage T

33 tithrombotic-associated ICH in the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage T

34 emonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneousl

35 An ad libitum NND produces weight loss and blood pressure reduction in centrally obese individuals.

36 by short-term dual antiplatelet treatment or blood pressure reduction in fairly young patients with r

37 Effects of blood pressure reduction in persons with grade 1 hyperte

38 perlipidemic men, with significant diastolic blood pressure reductions in the HYL group only.

39 Multivariate analyses implicate blood pressure reductions in the setting of an active va

40 Ventilatory support, blood-pressure reduction, intracranial-pressure monitori

41 Surgical sympathectomy for blood pressure reduction is an old but extremely efficac

42 actions of adults with stage I hypertension; blood pressure reduction is enhanced to a similar degree

43 FrEF, patients with HFpEF experience greater blood pressure reduction, less enhancement in cardiac ou

44 Excessive blood pressure reduction may contribute to poor outcome

45 s in hypertension have reported that similar blood pressure reductions may not necessarily translate

46 This effect, which was independent of blood pressure reduction, may account for the improved c

47 We did a meta-analysis of blood pressure reductions on relative risk (RR) of major

48 tment LV mass, body weight, the magnitude of blood pressure reduction, race, and age may modify the r

49 hieve their effect, it remains the case that blood pressure reduction remains more important than the

50 Beyond blood pressure reduction, statin therapy is undoubtedly

51 ne achieved a greater systolic and diastolic blood pressure reduction than fosinopril (10 mm Hg versu

52 The blood pressure reduction that would result from a substa

53 c targeting of aldosterone excess as well as blood pressure reduction to minimize cardiac morbidity i

54 The cornerstone of treatment remains blood pressure reduction, using agents with both antihyp

55 The average blood pressure reduction was about 3.6/2.4 mm Hg.

56 This trial did not examine whether the blood pressure reduction was due to protein or isoflavon

57 Blood pressure reduction was greater in adolescents with

58 e a higher rate of worsening renal function, blood pressure reduction was not associated with worseni

59 Blood pressure reduction was not significantly different

60 The net changes in systolic and diastolic blood pressure reductions were -7.88 mm Hg (CI, -4.66 to

61 Blood pressure reduction with once-daily diltiazem decre

62 Similar blood pressure reduction with once-daily nifedipine did

63 led promising results for safe and sustained blood pressure reduction with percutaneous renal sympath

64 The greater blood pressure reductions with SR may be mediated in par

65 In a general population, this blood pressure reduction would substantially reduce the